Can AI do scientific research? Billions chase hopes of superintelligencenews2026-05-26T15:00:33+00:00May 26th, 2026|Endpoints News|
Fetal gene therapy’s progress calls into question the taboo on embryo editingnews2026-05-20T14:10:34+00:00May 20th, 2026|Endpoints News|
Bristol Myers reaches a crossroads as a make-or-break year takes shapenews2026-04-29T15:33:16+00:00April 29th, 2026|Endpoints News|
Exclusive: UC Berkeley startup bets on jumping genes for GLP-1 gene therapynews2026-04-24T14:00:16+00:00April 24th, 2026|Endpoints News|
How a 20-year old asthma drug is boosting food allergy researchnews2026-04-01T15:04:06+00:00April 1st, 2026|Endpoints News|
A simpler form of DNA may be key to non-viral gene therapy, study suggestsnews2026-03-12T15:31:55+00:00March 12th, 2026|Endpoints News|
Compounders prescribing GLP-1s put pricing pressure on Novo, Lillynews2026-03-12T13:00:36+00:00March 12th, 2026|Endpoints News|
Eli Lilly CEO David Ricks seeks ‘exit velocity’ for pharma’s futurenews2026-03-11T14:37:56+00:00March 11th, 2026|Endpoints News|
China is taking on the world’s 10 most expensive medicinesnews2026-03-05T15:00:17+00:00March 5th, 2026|Endpoints News|
Novo Nordisk’s ‘strategic conundrum’: How being anchored to the past could cost it the futurenews2026-02-27T12:11:21+00:00February 27th, 2026|Endpoints News|
